← Insider buys
SYRS

Syros Pharmaceuticals, Inc. · Healthcare

Chief Scientific Officer Eric R Olson sold $59K of Syros Pharmaceuticals, Inc.

Sold$58,969
$23.59Price
2,500Shares
−100%Stake

What SYRS did after the filing

Prices for SYRS after this filing aren't in yet.

Traded Mon, Aug 7. Filed Tue, Aug 8, 1:20 PM ET, during the session. Not investment advice.